The FTSE 100 ended a difficult week firmly in negative territory on Friday, dragged lower by surging oil prices and growing unease over artificial intelligence investment returns. The blue-chip index closed down
The rapid adoption of autonomous AI systems is exposing a dangerous gap between the risks businesses face and the coverage their insurance policies actually provide. As AI agents operate with increasing independence,
More
Palo Alto Networks (PANW) and Hewlett Packard Enterprise (HPE) were among several stocks drawing significant attention from investors in recent trading sessions. Markets continue to see sharp single-day moves in individual equities,
More
A FTSE 250 company has seen its share price collapse by 95% over the past five years, raising questions about whether it represents a contrarian buying opportunity. Such a dramatic decline places
More
WuXi AppTec has secured an early legal victory in its fight against the US Department of Defense over its controversial designation as a “Chinese military company.” Chief Judge James E. Boasberg of
More
Londoners are set to witness the deepest partial solar eclipse the capital has seen in over 25 years on Wednesday evening. The Moon will cover roughly 91% of the Sun at its
More
In a notable decision issued in June 2026, the Delaware Court of Chancery provided significant guidance on how conflicting forum selection clauses should be reconciled across related agreements. The case, Kelly Roofing
More
Chief Judge Emily Marks of the Middle District of Alabama has denied the Southern Poverty Law Center’s motion to dismiss its 11-count federal indictment on grounds of vindictive prosecution. The SPLC had
More
A fresh standoff between the United States and Iran has rattled financial markets, driving oil prices upward and putting pressure on equities across global exchanges. The escalating tensions between Washington and Tehran
More
Stockopedia analysts have recorded a 36.9% return in FTSE 250 names year to date, a performance that is drawing significant attention from investors watching mid-cap markets. The FTSE 250 index, which tracks
More
ITM Isotope Technologies Munich SE has received a Complete Response Letter from the U.S. Food and Drug Administration, blocking approval of its cancer drug ITM-11. The FDA issued the CRL on August
More